Treatment
-
From the Editor-in-Chief
Cancer Epigenetics: Disorganization Drives DysfunctionEmerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.
by William G. Nelson, MD, PhD
-
Forward Look
Cryoablation May Be a Treatment Option for Some PatientsProcedure uses extreme cold to kill cancer cells.
by Christina Bennett
-
Forward Look
More Options to Prevent Blood Clots in High-Risk Cancer PatientsUpdated guidelines support use of oral blood thinners.
by Jane Langille
-
Q&A
A Different MountaintopScience writer Charles Graeber describes how a shift in researchers' understanding of immune function and cancer is leading to effective treatments.
by Marci A. Landsmann
-
Forward Look
New Guidelines for Radiation Therapy in Pancreatic CancerRecommendations address conflicts and research gaps.
by Ashley P. Taylor
-
Forward Look
Managing Opioid-Related ConstipationPatients may be wary of discussing this common side effect.
by Sue Rochman
-
Can CRISPR Deliver?A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
-
The Puzzle of Pancreatic CancerPancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
-
The Coronavirus and Cancer CareCancer patients in the U.S. are feeling impacts from the new coronavirus.
by Kate Yandell
-
Medicare Coverage for Next-Generation Sequencing TestsMultigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
